The FDA ordered genetic-testing startup 23andMe to stop marketing its mail-order DNA kit, saying there are risks of inaccurate results and the company hasn't worked with the agency to gain approval.
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304281004579219893863966448.html?mod=pls_whats_news_us_business_f
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304281004579219893863966448.html?mod=pls_whats_news_us_business_f
Nessun commento:
Posta un commento